AlphaQuest LLC Acquires 2,243 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

AlphaQuest LLC boosted its holdings in Simulations Plus, Inc. (NASDAQ:SLP) by 502.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,689 shares of the technology company’s stock after acquiring an additional 2,243 shares during the quarter. AlphaQuest LLC’s holdings in Simulations Plus were worth $75,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Proficio Capital Partners LLC bought a new position in Simulations Plus in the 4th quarter valued at approximately $719,000. Charles Schwab Investment Management Inc. lifted its position in Simulations Plus by 4.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 143,253 shares of the technology company’s stock valued at $3,995,000 after acquiring an additional 6,418 shares in the last quarter. Jones Financial Companies Lllp lifted its position in Simulations Plus by 53.6% in the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock valued at $34,000 after acquiring an additional 427 shares in the last quarter. US Bancorp DE lifted its position in Simulations Plus by 14.3% in the 4th quarter. US Bancorp DE now owns 5,687 shares of the technology company’s stock valued at $159,000 after acquiring an additional 713 shares in the last quarter. Finally, Illumine Investment Management LLC bought a new position in Simulations Plus in the 4th quarter valued at approximately $280,000. 78.08% of the stock is owned by institutional investors.

Simulations Plus Price Performance

NASDAQ:SLP opened at $25.51 on Thursday. The firm has a market capitalization of $512.55 million, a price-to-earnings ratio of 63.78 and a beta of 0.89. Simulations Plus, Inc. has a one year low of $24.00 and a one year high of $51.22. The business has a fifty day moving average price of $31.42 and a 200-day moving average price of $31.03.

Analysts Set New Price Targets

Several research firms have recently weighed in on SLP. William Blair reissued an “outperform” rating on shares of Simulations Plus in a report on Wednesday, January 8th. KeyCorp increased their price target on Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $49.40.

Insider Transactions at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total value of $678,200.00. Following the completion of the sale, the director now directly owns 3,402,584 shares in the company, valued at $115,381,623.44. This represents a 0.58 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 19.40% of the stock is currently owned by company insiders.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.